Please ensure Javascript is enabled for purposes of website accessibility
Thyroid Tablets USP

Thynuvi is a prescription natural desiccated thyroid (NDT) medication available in seven strengths to support individualized treatment decisions made between patients and their healthcare providers.

Precise
More dosing options than most NDT products, including 45 mg and 75 mg intermediate strengths for individualized thyroid therapy.

Simple
Contains four inactive ingredients in a thoughtfully simple formulation, made without corn starch, dextrose, mineral oil, lactose, gluten, or artificial colors.

Reliable
Transparent U.S. sourcing and manufacturing, providing visibility into where Thynuvi is made and where its active ingredient is sourced.

UNDERSTANDING HYPOTHYROIDISM

Hypothyroidism is a condition that occurs when the thyroid gland does not make enough thyroid hormones to meet the body’s needs. Because thyroid hormones help regulate how the body uses energy, too little thyroid hormone can cause many body processes to slow down. Healthcare providers diagnose hypothyroidism using blood tests together with a person’s symptoms, medical history, and physical examination.

Symptom Can Vary

People with hypothyroidism may experience symptoms such as fatigue, feeling cold, dry skin, constipation, slowed thinking, mood changes, or changes in weight. These symptoms can have many causes and do not confirm hypothyroidism on their own.

Talk with a Healthcare Provider
If you have new or persistent symptoms, ask a qualified healthcare provider for an evaluation. This website does not provide a diagnosis or individualized medical advice.

Understanding NDT

Natural desiccated thyroid (NDT) is derived from animal thyroid tissue and is used in certain prescription thyroid products. Thyroid products differ in their active hormones, inactive ingredients, strengths, and prescribing considerations. A healthcare provider can explain the available options and determine an appropriate treatment plan.

Indications

Thynuvi Thyroid Tablets USP are indicated as replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism.

Thynuvi is also indicated as pituitary TSH suppressants, in the treatment or prevention of various types of euthyroid goiters, including thyroid nodules, subacute or chronic lymphocytic thyroiditis (Hashimoto’s), multinodular goiter, and in the management of thyroid cancer.

Patient Note
Different thyroid medicines are not automatically interchangeable. Do not start, stop, switch, or change your dose without guidance from your healthcare provider.

PRESCRIBING INFORMATION

Seven Strengths for Individualized Prescribing